• No questions for this search term

Which consortium or company is most economically successful for covid-19 vaccine development?

Back to ranking

Transactions by Mukund Thiyagarajan

Amounts in Credits
Timestamp Answer option Long (for) Short (against) Shares Price % P&L (in Credits)
Total 200.13 0.00 +0.13
2020/08/17 12:54:37   T AZD1222 (ChAdOx1 nCoV-19): Oxford University, AstraZeneca 100.00 - 518.54 19.29 -100.00
2024/11/23 18:53:38   M AZD1222 (ChAdOx1 nCoV-19): Oxford University, AstraZeneca 100.13 - 518.54 19.35 +100.13
O=Opening valuation, M=Market valuation, C=Closing valuation, T=Trade, R=Reversal, S=Settlement